Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV003408466 | SCV004112300 | uncertain significance | DNMT3A-related disorder | 2023-06-01 | criteria provided, single submitter | clinical testing | The DNMT3A c.183+1G>A variant is predicted to disrupt the GT donor site and interfere with normal splicing. Using an alternate transcript (NM_175629), this variant is a deep intronic variant (c.640-3659G>A) that is not predicted to impact splicing based on available prediction programs (Alamut Visual Plus v1.6.1). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |